Patch Testing in Individuals With Diabetes Using Medical Devices. Part 2—Contact Allergy to Medical Device Allergens and New Patch Test Recommendations
Contact Dermatitis · 2026-08 · 95 (2) · 169-181
DOI: 10.1111/cod.70149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, online erschienen am 05.04.2026. Verfasst von Josefin Ulriksdotter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Patch Tests, Diabetes Mellitus, Type 1, Allergens. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Stig and Ragna Gorthon Foundation, HudFonden, Svenska Diabetesstiftelsen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Previous studies on contact allergy to diabetes medical devices (MDs) are based on patients referred for patch testing due to suspected allergic contact dermatitis.
Objectives
To present real‐world data on contact allergy to MD allergens among diabetes MD users. To suggest a MD patch test series.
Methods
Adults with type 1 diabetes using diabetes MDs followed up at two endocrinology departments were invited to be patch tested with a novel MD patch test series.
Results
Of the 204 participants (114 with skin rash to diabetes MDs, 90 without), 16.2% were positive to allergens found in diabetes MDs. The prevalence was significantly higher in those with skin rash to diabetes MDs versus without (28.1% vs. 1.1%; adjusted p ‐value < 0.001). For allergens found in diabetes MDs, the highest contact allergy rates were seen to isobornyl acrylate (10.3%), N,N‐ dimethylacrylamide (4.9%), 2‐hydroxyethyl acrylate (3.4%), and dicyclohexylmethane‐4,4′‐diisocyanate (2.9%).
Conclusions
Among diabetes MD users, the prevalence of contact allergy to MD allergens was remarkably high. 2‐hydroxyethyl acrylate has not previously been reported as a culprit allergen in diabetes MDs, which underlines the importance of repeated chemical analyses and continuous update of the MD series. A better prevention of MD‐related contact allergies is called for.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.
ORCID-Profile: Josefin Ulriksdotter, Martin Mowitz, Magnus Bruze, Nils Hamnerius
Förderung
- The Stig and Ragna Gorthon Foundation
- HudFonden
- Svenska Diabetesstiftelsen
- Astma- och Allergiförbundet
Zitieren
APA
Ulriksdotter, J., Mowitz, M., Sukakul, T., Bruze, M., Hamnerius, N., & Svedman, C. (2026). Patch Testing in Individuals With Diabetes Using Medical Devices. Part 2—Contact Allergy to Medical Device Allergens and New Patch Test Recommendations. Contact Dermatitis, 95(2), 169-181. https://doi.org/10.1111/cod.70149
Vancouver
Ulriksdotter J, Mowitz M, Sukakul T, Bruze M, Hamnerius N, Svedman C. Patch Testing in Individuals With Diabetes Using Medical Devices. Part 2—Contact Allergy to Medical Device Allergens and New Patch Test Recommendations. Contact Dermatitis. 2026;95(2):169-181. doi:10.1111/cod.70149
BibTeX
@article{Ulriksdotter2026,
author = {Ulriksdotter, Josefin and Mowitz, Martin and Sukakul, Thanisorn and Bruze, Magnus and Hamnerius, Nils and Svedman, Cecilia},
title = {Patch Testing in Individuals With Diabetes Using Medical Devices. Part 2—Contact Allergy to Medical Device Allergens and New Patch Test Recommendations},
journal = {Contact Dermatitis},
year = {2026},
volume = {95},
number = {2},
pages = {169--181},
doi = {10.1111/cod.70149}
}
EUVIMED